Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast in Diabetic Nephropathy
NCT04755946Phase 3Unknown
- Sponsor
- Tanta University
- Start
- Mar 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of roflumilast in diabetic nephropathy (DN), sponsored by Tanta University. Status: unknown.
02
Drugs
roflumilast
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT04755946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04755946.